Joseph Fuisz

Joseph Fuisz
Born Joseph M. Fuisz
Residence United States
Nationality American
Ethnicity Slovenian
Alma mater Yale University and the Columbia Law School
Occupation Founder of Fuisz Pharma LLC
Organization Fuisz Pharma LLC
Known for Patents, Inventor on over 40 of MonoSol Rx's thin film patents,[1] Inventor of Suboxone[2]
Spouse(s) Helena Robinson
Parent(s) Richard Fuisz and Patricia Fuisz
Website fuisz.com

Joseph Fuisz is an American attorney, inventor, and entrepreneur of Slovenian descent. He works predominantly in the pharmaceutical industry as the founder of Fuisz Pharma LLC. As of October 2015, he is named on 32 medical patents.[3][4]

He has been involved in the development of drug delivery and the approval of new drugs and low emission tobacco products.[5][6] Joseph Fuisz is a named inventor of the formulation of the drug, Suboxone.[7] The sales of Suboxone in 2013 were reported to be $1.2 billion in the United States.[8]

Early life & education

Joseph Fuisz is the son of Richard Fuisz and Patricia Fuisz. He graduated from Yale University and Columbia Law School.[9]

Career

Joseph Fuisz began his career in law, after graduating from Columbia University. He passed the New York Bar exam and began practising law at Sullivan & Cromwell.[10] He subsequently moved into medical patents, a field his father Richard Fuisz had worked in for a number of years.

In 2000, Joseph Fuisz and Richard Fuisz founded International Fluidics, which was rebranded as Kosmos Pharma Limited two years later.[11] Richard began as the more senior figure in the company, before the sale of the company in 2004. The rebranding came at a time when the company filed a number of patents that successfully allow highly sensitive proteins to be taken orally.[12] One example of this came in 2002, the company successfully developed stamp-size medicine strips that could dissolve quickly in a patient's mouth.[13]

Kosmos Pharma Limited was acquired by MonoSol LLC in 2004, with Joseph Fuisz becoming MonoSol's Senior Vice President.[14] Joseph Fuisz eventually moved back to Fuisz LLC, concentrating on drug delivery patents.[15]

Joseph Fuisz is also a named inventor in the Orange Book for the drug, Suboxone.[16] It is a formulation of the Buprenorphine and is used for the treatment of opioid addiction in higher dosages, and to control pain lower doses, with dosage depending on the severity.[17] The drug is also used for the treatment of heroin addiction, and since 2014 has been valued at over $1 billion in sales annually by its provider, Indivior.[18]

MonoSol Rx announced they had acquired a patent from Joseph Fuisz in 2012. The patent was related to drug delivery and the use of film single layer multifunctional films. The medical patent provides for a non-uniform distribution of components.[19] The thickness direction of a layer of biocompatible film, which allows for a multifunctional film to be used in a traditional single layer.[20]

While working in the medical drug delivery market, Joseph Fuisz founded Fuisz Tobacco, which was a subsidiary of Fuisz Inc.[21][22]

He became the Managing Director of the company in 2008.[23] Fuisz Tobacco developed a dissolving tobacco film strip. Joseph Fuisz claimed improved nicotine absorption from tobacco in this format.[24] The patent for this system is assigned to Philip Morris International.[25]

Joseph Fuisz's next major advancement in tobacco came in September 2013, when he patented a delivery mechanism that used a coating. The coating, allowed for an increase in the local Ph within the body, which led to maximised nicotine absorption.[23]

Joseph Fuisz has developed new tablet shapes that allow for improved esophageal transit.[16] The US Patent Office issued a patent for this work in 2015.[26]

In 2014, Joseph Fuisz and a blood-testing patent he filed were involved in a dispute with another medical research company.[27] Theranos accused Joseph Fuisz and his father Richard Fuisz of stealing documents of a patent they were to file. A parallel case against McDermott, Will & Emery was dismissed by a judge in late 2014, stating there was no evidence of theft.[28][29]

Personal life

Joseph Fuisz married his wife Helena Robinson in 2006.[9]

See also

External links

References

  1. ↑ "Fuisz Announces Formation of Fuisz Tobacco; Company to Commercialize Film- Based Smokeless Tobacco Products". PR News Wire.
  2. ↑ "Generic Suboxone Availability". Drugs.com.
  3. ↑ "Patents by Inventor Joseph M. Fuisz". Justia Patents.
  4. ↑ "Joseph M Fuisz". Patents buddy.
  5. ↑ "Fuisz Announces Formation of Fuisz Tobacco; Company to Commercialize Film- Based Smokeless Tobacco Products". PR News Wire. January 2015.
  6. ↑ "Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit". Google Patents.
  7. ↑ "Generic Suboxone Availability". Drugs.com.
  8. ↑ "So You Thought You Could Get Off Suboxone?". PR News Wire.
  9. 1 2 "Helena Robinson and Joseph Fuisz wed". NY Times. January 22, 2006.
  10. ↑ "Pro Se Patentees to Fight David Boies in San Jose Trial". Law.com. March 12, 2014.
  11. ↑ "Kosmos Pharma Limited". Zoominfo.
  12. ↑ Hirani, Jaysukh J; Rathod, Dhaval A (April 2009). "Orally Disintegrating Tablets: A Review". Tropical Journal of Pharmaceutical Research.
  13. ↑ McCarthy, Ellen (September 16, 2002). "Kosmos Pharma Develops a Dose of Convenience". Washington Post.
  14. ↑ "MonoSol LLC and Kosmos Pharma Form MonoSolRX LLC to Commercialize Oral Film Strip Pharmaceutical Products". Pharmaceutical Processing. March 2, 2004.
  15. ↑ MacDonald, Gareth (January 24, 2013). "Can't Swallow Esophageal Transit Failure? Fuisz says New Pill Design Can Help". In-PharmaTechnologist.
  16. 1 2 "Subutex and Suboxone Questions and Answers". FDA.
  17. ↑ "Buprenorphine". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. 14 January 2014. Retrieved 6 April 2014.
  18. ↑ Stanton, Dan (February 12, 2014). "Suboxone sales down as opioid addiction market Intensifies". In-Pharmatechnologist.
  19. ↑ MacDonald, Gareth (April 7, 2011). "Fuisz develops Easier to Swallow Dosage Form". In-PharmaTechnologist.
  20. ↑ "MonoSol Rx Acquires U.S. Patent for Multifunctional Single Layer Film Drug Delivery Technology". MonoSol Rx.
  21. ↑ "2012 Global Tobacco Networking Forum". Tobacco Reporter.
  22. ↑ "Fuisz Announces Formation of Fuisz Tobacco; Company to Commercialize Film". PR Newswire. January 15, 2012.
  23. 1 2 "Fuisz Tobacco Announces Issuance of Patent for Improved Nicotine Delivery from a Tobacco Pouch". Market Watch. September 23, 2013.
  24. ↑ "Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product". PR Newswire. May 20, 2013.
  25. ↑ "Extrudable and extruded compositions for delivery of bioactive agents, method of making same and method of using same". Google Patents.
  26. ↑ "Solid dosage form that promotes reliable oral, esophageal and GI transit". US Patent Office.
  27. ↑ Wolfe, Jan (September 24, 2013). "Judge OKs Ex-McDermott Client's Suit Over Alleged IP Theft". The Recorder.
  28. ↑ Cassens Weiss, Debra (March 14, 2014). "Patent theft suit blames former McDermott partner; defense sees 'smoke and mirrors'". ABA Journal.
  29. ↑ Tillman, Zoe (August 5, 2013). "Malpractice Suit Against McDermott Dismissed". Legal Times.
This article is issued from Wikipedia - version of the Tuesday, January 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.